Platelet Transfusions in the PICU: Does Disease Severity Matter?

Area of Science:

• Pediatric Critical Care Medicine
• Hematology
• Transfusion Medicine

Background:

• Platelet transfusions are common in pediatric intensive care units (PICUs).
• Limited data exist on current platelet transfusion practices and outcomes in critically ill children.
• Understanding these practices is crucial for optimizing patient care.

Purpose of the Study:

• To evaluate current platelet transfusion practices in a pediatric intensive care unit.
• To assess platelet transfusion-related outcomes in critically ill children.
• To investigate the association between platelet transfusions, disease severity, and mortality.

Main Methods:

• Retrospective cohort study conducted from January 2010 to March 2016.
• Included children under 19 years old who received platelet transfusions in a tertiary-level PICU.
• Analyzed transfusion data, patient characteristics, and mortality rates, adjusting for disease severity (Pediatric Risk of Mortality-3 score).

Main Results:

• Platelet transfusions were given to 2.4% of PICU patients.
• Patients receiving transfusions had higher mortality (30% vs 2.3%) and disease severity scores.
• The odds of dying varied based on disease severity, with increased odds at lower scores and decreased odds at higher scores.

Conclusions:

• Platelet transfusion outcomes in critically ill children are influenced by underlying disease severity.
• Mortality risk associated with platelet transfusions appears dependent on the Pediatric Risk of Mortality-3 score.
• Further prospective trials are needed to confirm these findings and guide prophylactic transfusion strategies.